Building Your Care Team
At a Glance
To effectively manage Restless Legs Syndrome (RLS), seek out a sleep medicine specialist or neurologist up-to-date with 2024 AASM guidelines. A knowledgeable doctor will target ferritin levels over 75 ng/mL and avoid dopamine agonists as a first-line treatment to prevent symptom worsening.
Restless Legs Syndrome (RLS) is a chronic neurological condition that requires long-term management and a specialized medical partnership. Because the “standard of care” for RLS has changed significantly with the release of the 2024 American Academy of Sleep Medicine (AASM) guidelines, finding a doctor who is current on these shifts is critical to your long-term health [1].
Choosing Your Care Team
Not all doctors are familiar with the specific biological needs of an RLS patient. You should ideally seek out specialists who focus on the brain and sleep [2]:
- Sleep Medicine Specialists: These providers are often the most current on the relationship between RLS, iron deficiency, and sleep-disordered breathing.
- Neurologists: Because RLS is a sensorimotor neurological disorder, neurologists specialize in the brain pathways involved in your symptoms [3].
- Movement Disorder Specialists: These are neurologists with extra training in conditions like Parkinson’s and RLS. They are particularly skilled at managing augmentation—the treatment-induced worsening of symptoms [4][5].
The Risks of “Wait and See”
Leaving RLS untreated or poorly managed does more than just steal your sleep; it can impact your long-term physical and mental health:
- Cardiovascular Health: Chronic RLS is linked to a slightly increased risk of hypertension (high blood pressure) [6]. This is likely because the constant “urge to move” and sleep loss keep your nervous system in a state of high alert, increasing peripheral vascular resistance [7][8].
- Psychological Impact: The toll of “invisible” symptoms and chronic exhaustion leads to significantly higher rates of depression and anxiety [9][10]. In adults, RLS is also frequently associated with symptoms of ADHD [11].
Lifestyle and Behavioral Management
While most moderate-to-severe RLS requires medical treatment, certain lifestyle changes can provide a vital foundation for relief [12]:
- Eliminate Aggravating Factors: Many “everyday” substances act as triggers. Caffeine, alcohol, and nicotine can significantly worsen symptoms [12].
- Review Your Medications: Stay away from OTC triggers like melatonin or sedating cold medicines, as discussed in Why Me? Genetics, Iron, and Triggers.
- Exercise Wisely: While light stretching or yoga can help relieve symptoms, intense or heavy exercise close to bedtime can actually trigger severe RLS flare-ups. Timing your workouts earlier in the day is crucial.
- Non-Drug Aids: Some patients find relief using weighted blankets or following strict sleep hygiene protocols (like a cool, dark room and a consistent bedtime) [13][14].
Vetting Your Provider
A doctor who is up-to-date with the 2024 guidelines will have a specific “clinical signature.” They should:
- Aim for a target ferritin level of at least 75 ng/mL and a TSAT of at least 20%, rather than just saying your iron is “normal” [1].
- Suggest alpha-2-delta ligands (like gabapentin or pregabalin) as the first medication option rather than dopamine agonists [5].
- Discuss the risks of augmentation and have a plan to monitor you for it [15].
- Be open to discussing intravenous (IV) iron if your oral supplements aren’t working or if your ferritin is in the 75–100 ng/mL range [16][17].
If your current provider is simply increasing your dose of a dopamine agonist as your symptoms get worse, it may be time to seek a second opinion from an RLS specialist [4][5].
Common questions in this guide
What type of doctor treats Restless Legs Syndrome?
What ferritin level should an RLS patient target?
What are the risks of leaving RLS untreated?
Are there lifestyle changes that help manage RLS?
What does it mean if my RLS symptoms start earlier in the day?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do you follow the 2024 AASM clinical practice guidelines for RLS management?
- 2.What is your target ferritin and TSAT level for an RLS patient, and how does it differ from a standard lab's 'normal' range?
- 3.If my symptoms start earlier in the day, do you recommend increasing my current dose or screening for augmentation?
- 4.Are you comfortable managing the transition from a dopamine agonist to a gabapentinoid or low-dose opioid if my current treatment fails?
- 5.Should we consider intravenous iron (like ferric carboxymaltose) if my ferritin is between 75 and 100 ng/mL?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline.
Winkelman JW, Berkowski JA, DelRosso LM, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(1)):137-152 doi:10.5664/jcsm.11390.
PMID: 39324694 - 2
Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review).
Vlasie A, Trifu SC, Lupuleac C, et al.
Experimental and therapeutic medicine 2022; (23(2)):185 doi:10.3892/etm.2021.11108.
PMID: 35069866 - 3
The complexities in the differential diagnosis of restless legs syndrome (Willis-Ekbom disease).
Poplawska-Domaszewicz K, Rota S, Qamar MA, Chaudhuri KR
Expert review of neurotherapeutics 2025; (25(2)):157-173 doi:10.1080/14737175.2025.2450639.
PMID: 39773238 - 4
Restless legs syndrome with augmentation successfully treated with IV iron.
LaBarbera V, Trotti LM, Rye D
Neurology. Clinical practice 2017; (7(3)):e26-e28 doi:10.1212/CPJ.0000000000000276.
PMID: 28680768 - 5
Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update.
Salminen AV, Winkelmann J
Current treatment options in neurology 2018; (20(12)):55 doi:10.1007/s11940-018-0540-3.
PMID: 30411165 - 6
Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
Van Den Eeden SK, Albers KB, Davidson JE, et al.
Sleep 2015; (38(7)):1009-15 doi:10.5665/sleep.4800.
PMID: 26083613 - 7
Impact of Restless Legs Syndrome on Cardiovascular Autonomic Control.
Bertisch SM, Muresan C, Schoerning L, et al.
Sleep 2016; (39(3)):565-71 doi:10.5665/sleep.5528.
PMID: 26564128 - 8
Ocular morphological changes in patients with restless legs syndrome analyzed by optical coherence tomography.
Kocasarac C, Yigit Y, Trotti LM, Basaran S
Sleep medicine 2019; (57()):1-5 doi:10.1016/j.sleep.2019.01.024.
PMID: 30878898 - 9
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs.
Elrassas HH, Elsayed YAR, Abdeen MS, et al.
Human psychopharmacology 2022; (37(2)):e2817 doi:10.1002/hup.2817.
PMID: 34533852 - 10
Restless Legs Syndrome in Multiple Sclerosis.
Güneş T, Emre U, Erdal Y, Yalin OÖ
Noro psikiyatri arsivi 2021; (58(2)):94-98 doi:10.29399/npa.23429.
PMID: 34188589 - 11
Attention-deficit/hyperactivity and obsessive-compulsive symptoms in adult patients with primary restless legs syndrome.
Mazurie Z, Mayo W, Ghorayeb I
Applied neuropsychology. Adult 2024; (31(4)):639-646 doi:10.1080/23279095.2022.2057857.
PMID: 35382650 - 12
French consensus: Treatment of newly diagnosed restless legs syndrome.
Limousin N, Flamand M, Schröder C, Charley Monaca C
Revue neurologique 2018; (174(7-8)):515-521 doi:10.1016/j.neurol.2018.06.002.
PMID: 30054010 - 13
Weighted Blanket Therapy for Periodic Limb Movement Disorder: A Case Report Highlighting Improved Sleep Quality and Reduced Symptoms.
Nouman Aslam M, Kafle R, Shawl SH, et al.
Cureus 2023; (15(5)):e39622 doi:10.7759/cureus.39622.
PMID: 37388600 - 14
[Current issues of diagnosis and therapy of patients with restless legs syndrome].
Gorbachev NA, Balabanova MA, Zakharova AS, Poluektov MG
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2025; (125(10)):7-11 doi:10.17116/jnevro20251251017.
PMID: 41255313 - 15
Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.
García-Borreguero D
Sleep medicine clinics 2015; (10(3)):287-92, xiii.
PMID: 26329438 - 16
Iron therapy & restless legs syndrome: a narrative review.
Phan DM, Lam MY, Trang MN
Sleep & breathing = Schlaf & Atmung 2026; (30(4)).
PMID: 42371291 - 17
Efficacy and safety of intravenous iron in patients with restless legs syndrome with normal serum ferritin levels: a stratified subanalysis.
Garcia-Malo C, Garcia-Borreguero D, Silber MH
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(12)):2023-2029 doi:10.5664/jcsm.11846.
PMID: 40838695
This page provides information on finding an RLS care team for educational purposes only. Always consult your healthcare provider or a qualified specialist for personalized medical advice and treatment.
Get notified when new evidence is published on Restless Legs Syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.